Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Protagonist Therapeutics is a biopharmaceutical company focused on discovering and developing peptide-based therapeutics for hematology, inflammatory, and immunomodulatory diseases. Its pipeline includes novel peptides like rusfertide for polycythemia vera and icotrokinra for psoriasis and other inflammatory conditions. The company leverages proprietary peptide technology to create oral and injectable drugs, collaborating with partners like Takeda and J&J to address unmet medical needs in chronic diseases.
This description was generated via AI from an annual report. Updated about 1 year ago.